Splenectomy is an effective technique in living donor liver transplantation (LDLT) with small-for-size (SFS) liver grafts for overcoming SFS liver graft injury. However, the protective mechanism of splenectomy is still unclear. The aim of this study was to investigate how splenectomy could attenuate SFS graft injury through the measurement of biochemical factors, particularly the expression of endothelin (ET)-1, which is a key molecule of microcirculatory disorders by mediating sinusoidal vasoconstriction. We performed rat orthotopic liver transplantation using SFS liver grafts with or without splenectomy. We investigated intragraft expression of ET-1 mRNA and hepatic protein levels of ET-1. In addition, portal pressure, hepatic injury and morphological changes, and survival rate were evaluated. In result, intragraft ET-1 mRNA expression after SFS liver transplantation was significantly downregulated by splenectomy, and hepatic expression of ET-1 in SFS grafts was rarely observed. Splenectomy inhibited the increase in portal pressure, ameliorated SFS liver graft injury and improved the graft survival rate after SFS liver transplantation. In conclusion, splenectomy improved the SFS liver injury and decreased the expression of ET-1 by attenuating portal hypertension on SFS liver transplantation. Downregulation of intragraft ET-1 expression plays important roles in the protective mechanism of splenectomy in SFS liver transplantation.

Download full-text PDF

Source
http://dx.doi.org/10.1111/tri.12223DOI Listing

Publication Analysis

Top Keywords

sfs liver
36
liver transplantation
28
graft injury
16
liver
13
liver graft
12
expression et-1
12
sfs
11
splenectomy
9
liver grafts
8
protective mechanism
8

Similar Publications

Background: Extramedullary hematopoiesis (EMH) is usually seen in the reticuloendothelial system such as the spleen and liver; however, there have been rare case reports when EMH is seen in serous fluids (SFs). The aim of this study included analyzing the cytomorphological features of EMH in SFs in correlation with various clinicopathologic parameters and recognizing potential diagnostic pitfalls as well as their prognostic significance.

Methods: Clinicopathologic parameters and radiologic and pathologic information from the patients with a cytologic diagnosis of EMH were evaluated with cytology slides.

View Article and Find Full Text PDF
Article Synopsis
  • - Multitarget tyrosine kinase inhibitors (TKIs) are commonly used for treating hepatocellular carcinoma (HCC), but their effectiveness is limited by poor pharmacokinetics and bioavailability.
  • - To address this issue, researchers developed a silk fibroin (SF)-based nanomedicine that enhances TKI delivery by using folic acid for targeting HCC cells and leveraging the dynamic properties of SF.
  • - The nanomedicine encapsulates Lenvatinib (Leva), resulting in improved tumor targeting, reduced cell survival, and enhanced overall therapeutic outcomes, showing promise for better HCC treatment.
View Article and Find Full Text PDF

Alternative splicing (AS) plays an important role in the co-transcription and post-transcriptional regulation of gene expression during mammalian spermatogenesis. The dzo is the male F1 offspring of an interspecific hybrid between a domestic bull (Bos taurus ♂) and a yak (Bos grunniens ♀) which exhibits male sterility. This study aimed to identify the testis-specific genes and AS associated with hybrid male sterility in dzo.

View Article and Find Full Text PDF

Study of prognostic splicing factors in cancer using machine learning approaches.

Hum Mol Genet

June 2024

Center for Computational Systems Medicine, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, 7000 Fannin St Suite 600, Houston, Texas 77030, United States.

Splicing factors (SFs) are the major RNA-binding proteins (RBPs) and key molecules that regulate the splicing of mRNA molecules through binding to mRNAs. The expression of splicing factors is frequently deregulated in different cancer types, causing the generation of oncogenic proteins involved in cancer hallmarks. In this study, we investigated the genes that encode RNA-binding proteins and identified potential splicing factors that contribute to the aberrant splicing applying a random forest classification model.

View Article and Find Full Text PDF

Liver cancer is one of the leading causes of death that motivating scientists worldwide to synthesize novel chemotherapeutics. Ru(II)-polypyridyl complexes are extensively studied for possible therapeutic and cellular applications due to their tunable coordination chemistry, structural diversity, ligand-exchange kinetics, accessible redox states, and rich photophysical or photochemical properties. Herein, we have synthesized a series of Ru(II) polypyridyl complexes (1-3), where ox is oxalate (CO) and N^N is 1,10-phenanthroline (phen) (1), dipyrido[3,2-:2',3'-]quinoxaline (dpq) (2), and dipyrido[3,2,-:2',3'-]phenazine (dppz) (3).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!